Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 30 studies | 31% ± 16% | |
smooth muscle cell | 12 studies | 23% ± 5% | |
type I pneumocyte | 10 studies | 39% ± 11% | |
myofibroblast cell | 9 studies | 32% ± 14% | |
connective tissue cell | 8 studies | 38% ± 22% | |
pericyte | 5 studies | 20% ± 5% | |
adipocyte | 4 studies | 39% ± 22% | |
GABAergic neuron | 4 studies | 27% ± 10% | |
glutamatergic neuron | 4 studies | 30% ± 12% | |
endothelial cell | 3 studies | 40% ± 26% | |
interneuron | 3 studies | 35% ± 16% |
Insufficient scRNA-seq data for expression of COL12A1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 19954.76 | 457 / 459 | 95% | 188.88 | 1065 / 1118 |
esophagus | 88% | 18034.68 | 1274 / 1445 | 90% | 98.79 | 165 / 183 |
intestine | 87% | 15296.31 | 839 / 966 | 83% | 69.50 | 439 / 527 |
ovary | 100% | 35849.45 | 180 / 180 | 68% | 40.99 | 294 / 430 |
bladder | 95% | 7589.29 | 20 / 21 | 71% | 59.37 | 359 / 504 |
uterus | 99% | 30282.20 | 169 / 170 | 66% | 55.01 | 303 / 459 |
lung | 90% | 6844.56 | 521 / 578 | 67% | 54.87 | 778 / 1155 |
skin | 91% | 45678.60 | 1653 / 1809 | 50% | 34.15 | 234 / 472 |
prostate | 65% | 5473.93 | 159 / 245 | 67% | 42.68 | 337 / 502 |
stomach | 45% | 3661.95 | 160 / 359 | 87% | 80.37 | 248 / 286 |
ureter | 0% | 0 | 0 / 0 | 100% | 16.98 | 1 / 1 |
adipose | 100% | 24391.90 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 17224.68 | 1325 / 1335 | 0% | 0 | 0 / 0 |
thymus | 79% | 5503.11 | 514 / 653 | 19% | 7.82 | 114 / 605 |
pancreas | 3% | 191.87 | 10 / 328 | 91% | 106.10 | 162 / 178 |
kidney | 60% | 4380.89 | 53 / 89 | 34% | 13.64 | 308 / 901 |
adrenal gland | 59% | 3480.78 | 151 / 258 | 15% | 4.43 | 34 / 230 |
heart | 56% | 3675.45 | 479 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 49% | 36.49 | 22 / 45 |
muscle | 24% | 1472.11 | 195 / 803 | 0% | 0 | 0 / 0 |
spleen | 22% | 1229.26 | 53 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 10% | 2.14 | 3 / 29 |
liver | 1% | 36.30 | 2 / 226 | 6% | 1.91 | 26 / 406 |
brain | 1% | 45.71 | 32 / 2642 | 5% | 2.12 | 35 / 705 |
eye | 0% | 0 | 0 / 0 | 1% | 0.33 | 1 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030199 | Biological process | collagen fibril organization |
GO_0035987 | Biological process | endodermal cell differentiation |
GO_0007155 | Biological process | cell adhesion |
GO_0005615 | Cellular component | extracellular space |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0070062 | Cellular component | extracellular exosome |
GO_1903561 | Cellular component | extracellular vesicle |
GO_0005595 | Cellular component | collagen type XII trimer |
GO_0005576 | Cellular component | extracellular region |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0030020 | Molecular function | extracellular matrix structural constituent conferring tensile strength |
Gene name | COL12A1 |
Protein name | Collagen alpha-1(XII) chain Collagen type XII alpha 1 chain Collagen, type XII, alpha 1 |
Synonyms | COL12A1L |
Description | FUNCTION: Type XII collagen interacts with type I collagen-containing fibrils, the COL1 domain could be associated with the surface of the fibrils, and the COL2 and NC3 domains may be localized in the perifibrillar matrix. . |
Accessions | ENST00000345356.10 [Q99715-2] H0Y991 ENST00000416123.6 [Q99715-4] ENST00000419671.1 Q99715 B9EJB8 ENST00000425443.6 ENST00000493109.2 ENST00000322507.13 [Q99715-1] H0Y4P7 H0Y5N9 D6RGG3 ENST00000483888.6 |